期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

降血压药物的潜在不良反应及其预防 被引量：12

Potential adverse effects of antihypertensive drugs and their prevention
原文传递
导出
摘要 了解抗高血压药物的不良反应对高血压的长期治疗具有重要临床意义。本文回顾抗高血压药物的潜在不良反应如心脏抑制、肾损害及血钾异常等,其目的为有助于预防严重不良反应的发生和改善高血压患者的用药依从性。 Understanding of adverse reactions to antihypertensive drugs is of important clinical significance for long-term therapy of hypertension. This paper provide a review of the potential adverse reactions to antihypertensive drugs such as heart depression, renal damage, potassium abnormality, etc, The purpose of this review is to benefit the prevention of serious adverse reactions and improvement of medication compliance of patients with hypertension.
作者 温绍君 刘洁琳 刘雅 王佐广
机构地区 首都医科大学附属北京安贞医院北京市心肺血管疾病研究所
出处 《药物不良反应杂志》 2007年第3期172-176,共5页 Adverse Drug Reactions Journal
关键词 高血压 降血压药物 潜在不良反应 hypertension antihypertensive drug potential adverse effect
分类号 R595.3 [医药卫生—内科学]
  • 相关文献

参考文献25

  • 1Zicha S, Tsuji Y, Shiroshita-Takeshita A, et al. Betablockers as antiarrhythmic agents [J]. Handb Exp Pharmacol, 2006, (171):235-266.
  • 2Watson WA, Litovitz TL, Rodgers GC, et al. 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System[J]. Am J Emerg Med, 2003, 21(5):353-421.
  • 3DeWitt CR, Waksman JC. Parmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity[J]. Toxicol Rev, 2004, 23(4):223-238.
  • 4Olson KR, Erdman AR, WoolfAD, et al. Calcium channel blocker ingestion: an evidence-based consensus guideline for out-of-hospital management [J]. Clin Toxicol (Phila), 2005, 43(7):797-822.
  • 5Edoute Y, Nagachandran P, Svirski B, et al. Cardiovascular adverse drug reaction associated with combined beta-adrenergic and calcium entry-blocking agents [J]. J Cardiovasc Pharmacol, 2000,35(4):556-559.
  • 6孟卫平.卡托普利致Ⅱ度窦房传导阻滞1例[J].中华老年医学杂志,1997,16(3):189-189.
  • 7Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group[J]. Arch Intem Med, 1998, 158(7):741-751.
  • 8Franse LV, Pallor M, Di Bari M, et al. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program[J]. Hypertension, 2000,35(5): 1025-1030.
  • 9Gehr TW, Sica DA. Pharmacotherapy in congestive heart failure: Hyperkalemia in congestive heart failure [J]. Congest Heart Fail, 2001, 7(2):97-100.
  • 10Zanabli AR, Yango A, Dworkin L. Incidence of hyperkalemia in high risk patients during treatment with an angiotensin converting enzyme inhibitor (Lisinopril)versus an angiotensin II receptor blocker (Losartan) [J]. SDJMed, 2004, 57(6):227-231.

二级参考文献26

  • 1[1]Fogari R, Zoppi A. Effects of antihypertensive therapy on sexual activity in hypertensive men. Curr Hypertens Rep 2002; 4 (3):202 - 10
  • 2[2]Lue TF. Erectile dysfunction. N Engl J Med 2000; 342(24): 1802 - 13
  • 3[3]Bulpitt J, Dollery CT, Came S. Changes insymptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38:121 - 8
  • 4[4]Grimm R, Grandits GA, Prineas RJ, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study(TOMHS) . Hypertens 1997;29:8 - 14
  • 5[5]Fogari R, Preti P, Derosa G, et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002; 58 (3): 177 - 80
  • 6[6]Toblli JE, Stella I, Inserra F, et al. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000; 13:686 -92
  • 7[7]Bragulat E, Sierra AD, Anronio M, et al. Endothelial dysfunction in salt-sensitive essential hypertension. Hypertens 2001; 37:444 - 8
  • 8[10]Melis MR, Argiolas A. Dopamine and sexual behaviour. Neurosci Biobehav Rev 1995;19:19 -38
  • 9[11]Sullivan ME, Thompson CS, Dashwood MR. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999; 43:658 - 65
  • 10[12]Virag R, Bouilly P, Frydman D Is impotence an arterial disorder?A study of arterial risk factors in 440 impotent men. Lancet 1985; 1:181 -4

共引文献22

同被引文献94

引证文献12

二级引证文献110

药物不良反应杂志
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部